Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. ASKA Pharmaceutical Holdings Co's Dividend Payout Ratio for the
months ended in Mar. 2026 was 1.78.
The historical rank and industry rank for ASKA Pharmaceutical Holdings Co's Dividend Payout Ratio or its related term are showing as below:
TSE:4886'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11 Med: 0.23 Max: 0.39
Current: 0.39
During the past 5 years, the highest Dividend Payout Ratio of ASKA Pharmaceutical Holdings Co was 0.39. The lowest was 0.11. And the median was 0.23.
TSE:4886's Dividend Payout Ratio is ranked worse than 50.56% of 445
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs TSE:4886: 0.39
During the past 5 years, the highest Trailing Annual Dividend Yield of ASKA Pharmaceutical Holdings Co was 2.95%. The lowest was 0.94%. And the median was 1.70%.
During the past 12 months, ASKA Pharmaceutical Holdings Co's average Dividends Per Share Growth Rate was 9.10% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 55.40% per year.
During the past 5 years, the highest 3-Year average Dividends Per Share Growth Rate of ASKA Pharmaceutical Holdings Co was 55.40% per year. The lowest was 54.20% per year. And the median was 54.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
ASKA Pharmaceutical Holdings Co (TSE:4886) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
ASKA Pharmaceutical Holdings Co Dividend Payout Ratio Related Terms
ASKA Pharmaceutical Holdings Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co Dividend Payout Ratio Chart
TSE:4886 vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ASKA Pharmaceutical Holdings Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASKA Pharmaceutical Holdings Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ASKA Pharmaceutical Holdings Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where ASKA Pharmaceutical Holdings Co's Dividend Payout Ratio falls into.
ASKA Pharmaceutical Holdings Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co (TSE:4886) has a Dividend Payout Ratio of 1.78 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. This is 674% above median its historical median of 0.23. Over the past decade, ASKA Pharmaceutical Holdings Co's Dividend Payout Ratio has ranged from 0.11 to 0.39. According to the industry distribution chart, ASKA Pharmaceutical Holdings Co ranks #225 out of 445 companies in the Drug Manufacturers industry, placing it in the top 50.6%.
Is ASKA Pharmaceutical Holdings Co's Dividend Payout Ratio too high?
ASKA Pharmaceutical Holdings Co's current Dividend Payout Ratio of 1.78 is 674% above median its 10-year median of 0.23. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.39. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. ASKA Pharmaceutical Holdings Co's value of 1.78 is 368.4% above this industry median. Based on the distribution chart, ASKA Pharmaceutical Holdings Co ranks #225 out of 445 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, ASKA Pharmaceutical Holdings Co has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ASKA Pharmaceutical Holdings Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ASKA Pharmaceutical Holdings Co ranks #225 out of 445 companies for Dividend Payout Ratio. This places ASKA Pharmaceutical Holdings Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. ASKA Pharmaceutical Holdings Co's value of 1.78 is 368.4% above this benchmark. Historically, ASKA Pharmaceutical Holdings Co's own Dividend Payout Ratio has ranged from 0.11 to 0.39 over the past decade. While the company's 10-year median is 0.23 vs. the industry median of 0.38, ASKA Pharmaceutical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ASKA Pharmaceutical Holdings Co's current Dividend Payout Ratio of 1.78 is 368.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASKA Pharmaceutical Holdings Co's current Dividend Payout Ratio is 1.78, which is 674% above median its own 10-year median of 0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASKA Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co (TSE:4886) is currently considered Fairly Valued. The stock's GF Value™ is 円2,402.52, compared to a current price of 円2,244.00 — trading 6.6% below its estimated fair value. The current Dividend Payout Ratio is 1.78, which is 674% above median its 10-year median of 0.23 and 368.4% above the Drug Manufacturers industry median of 0.38. ASKA Pharmaceutical Holdings Co's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For ASKA Pharmaceutical Holdings Co (TSE:4886), the current Dividend Payout Ratio is 1.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ASKA Pharmaceutical Holdings Co (TSE:4886) Overvalued in 2026?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of 円2,244.00 is trading 6.6% below its estimated GF Value™ of 円2,402.52.
GuruFocus considers ASKA Pharmaceutical Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4886:
Dividend Payout Ratio: 1.78 (674% above median its 10-year median of 0.23)
GF Value™: 円2,402.52 vs. price of 円2,244.00 (6.6% below fair value)
Industry Position: 368.4% above the Drug Manufacturers median (#225 of 445)
No single metric tells the full story. See the TSE:4886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ASKA Pharmaceutical Holdings Co Business Description
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and other related operations.
61GF Score
Get the complete analysis for TSE:4886
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4886 has been successfully added to your 
